PerkinElmer to Present at Evercore ISI HealthCONx Conference 2021

WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 16, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Evercore ISI 4th Annual HealthCONx Conference 2021 on Wednesday, December 1, 2021 at 10:30 a.m. ET. Prahlad Singh, president and chief executive officer of PerkinElmer, will provide... Read more

Bruker Announces Collaborative Advances in CCS-Enabled 4D Proteomics Workflows at HUPO

Co-marketing agreement with Cellenion on cellenONE® sample preparation system for automated label-free workflows for single-cell 4D proteomics on timsTOF SCP Seer Proteograph™ Product Suite combined with timsTOF Pro 2 and timsTOF SCP enables, deep, unbiased, rapid detection of >3000 protein groups from human plasma Co-marketing new PreOmics BeatBox for high-throughput, high-performance tissue, biopsy and cell... Read more

GE Healthcare Receives FDA Clearance for First X-ray AI to Help Assess Endotracheal Tube Placement

Critical Care Suite 2.0 helps clinicians assess Endotracheal Tube (ETT) placement for intubated patients, including critical COVID-19 patients The AI suite also includes algorithms that help radiologists prioritize critical cases and automate processes to help cut average review time from up to eight hours1 CHICAGO – November 15, 2021 – GE Healthcare today announced it... Read more

Thermo Fisher Scientific Advances Proteomics Through Select Collaborations and New Analytical Instrument Solutions

Thermo Fisher Scientific Advances Proteomics Through Select Collaborations and New Analytical Instrument Solutions The company will showcase their new chromatography and mass spectrometry solutions and collaborations at HUPO 2021 SAN JOSE, Calif., Nov. 15, 2021 /PRNewswire/ — HUPO — Thermo Fisher Scientific Inc., the world leader in serving science, today announced innovative proteomics solutions and... Read more

Bruker Announces Fourth Quarter 2021 Dividend

Plans to Increase 2022 Annual Dividend from $0.16 to $0.20 per share BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock. The dividend will be paid on December 17, 2021... Read more

Roche ranked as one of the top three most sustainable healthcare companies in the Dow Jones Sustainability Indices for the thirteenth year running

The ranking acknowledges Roche’s commitment to sustainability as an integral part of its business strategy Roche performed particularly well in Operational Eco-Efficiency, Environmental and Social Reporting Basel, 15 November 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) has again been recognised as one of the most sustainable companies in the Pharmaceuticals index of the Dow... Read more

Whole Slide Imaging of the Pancreas to Study Type 1 Diabetes

Type 1 diabetes is a chronic autoimmune disease in which the pancreas produces little or no insulin. Insulin is a hormone needed to allow sugar (glucose) to enter cells to produce energy. The exact cause of type 1 diabetes is unknown. Usually, the body’s own immune system mistakenly destroys the insulin-producing cells (called beta cells)... Read more

Thermo Fisher Scientific Selects Mebane, N.C. as Site for New Manufacturing Facility

Thermo Fisher Scientific Selects Mebane, N.C. as Site for New Manufacturing Facility $192.5 million U.S. government contract will help fund center of excellence to boost domestic supply of critically needed laboratory plastics WALTHAM, Mass., Nov. 12, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will build a state-of-the-art manufacturing... Read more

Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease

EU marketing authorisation follows approvals in Japan, the United Kingdom and Australia Approval based on data demonstrating Ronapreve reduced risk of hospitalisation in certain patients with mild to moderate disease and reduced risk of symptomatic COVID-19 infections in people exposed to the virus Basel, 12 November 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today... Read more

Xylem Inc. Declares Fourth Quarter Dividend of 28 Cents per Share

RYE BROOK, N.Y.–(BUSINESS WIRE)–Nov. 11, 2021– The Board of Directors of Xylem Inc. (NYSE: XYL) has declared a third quarter dividend of $0.28 per share payable on December 21, 2021 to shareholders of record as of November 23, 2021. About Xylem Xylem (XYL) is a leading global water technology company committed to solving critical water... Read more